Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
H2 2017
|
IRWD |
|
Phase 2b Results |
Other |
None |
|
H2 2017
|
MACK |
|
Phase 2 Results |
Autoimmune |
None |
|
H2 2017
|
MACK |
|
Phase 2 Results |
Oncology |
None |
|
H2 2017
|
MNTA |
|
Phase 2 Results |
Oncology |
Fast Track, Orphan Drug |
|
H2 2017
|
MRUS |
|
Phase 1/2 Results |
Oncology |
None |
|
H2 2017
|
NBIX |
|
NDA Submission |
Endocrine |
None |
|
H2 2017
|
NBRV |
|
Phase 3 Results |
Respiratory |
Fast Track |
|
H2 2017
|
OMED |
|
Phase 2 Results |
Oncology |
None |
|
H2 2017
|
OTIC |
|
Phase 3 Results |
Neurology |
Fast Track |
|
H2 2017
|
PSTI |
|
Phase 2 Results |
Cardiovascular |
Orphan Drug |
|